Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > FDA authorizes Prenosis software as first AI tool that....

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Apr 03, 2024 12:09pm

138 Views

Post# 35967899

RE:FDA authorizes Prenosis software as first AI tool that....

I like it !

The faster they can diagnose Sepsis the quicker the more deadly ESS can be diagnosed with the help of the EAA and the quicker patients can get on PMX

I would venture to say that too many patients do not get properly diagnosed until it is far too late.

Better early than late

MM

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale